全文获取类型
收费全文 | 1170篇 |
免费 | 99篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 15篇 |
儿科学 | 55篇 |
妇产科学 | 43篇 |
基础医学 | 153篇 |
口腔科学 | 34篇 |
临床医学 | 103篇 |
内科学 | 204篇 |
皮肤病学 | 46篇 |
神经病学 | 45篇 |
特种医学 | 42篇 |
外科学 | 222篇 |
综合类 | 29篇 |
预防医学 | 80篇 |
眼科学 | 37篇 |
药学 | 117篇 |
中国医学 | 4篇 |
肿瘤学 | 44篇 |
出版年
2023年 | 13篇 |
2022年 | 29篇 |
2021年 | 50篇 |
2020年 | 32篇 |
2019年 | 42篇 |
2018年 | 55篇 |
2017年 | 38篇 |
2016年 | 26篇 |
2015年 | 48篇 |
2014年 | 42篇 |
2013年 | 59篇 |
2012年 | 98篇 |
2011年 | 94篇 |
2010年 | 49篇 |
2009年 | 36篇 |
2008年 | 34篇 |
2007年 | 42篇 |
2006年 | 51篇 |
2005年 | 48篇 |
2004年 | 50篇 |
2003年 | 35篇 |
2002年 | 27篇 |
2001年 | 12篇 |
2000年 | 25篇 |
1999年 | 15篇 |
1998年 | 8篇 |
1997年 | 7篇 |
1995年 | 5篇 |
1994年 | 10篇 |
1993年 | 10篇 |
1992年 | 16篇 |
1991年 | 15篇 |
1990年 | 11篇 |
1989年 | 6篇 |
1988年 | 15篇 |
1987年 | 4篇 |
1986年 | 4篇 |
1985年 | 6篇 |
1984年 | 7篇 |
1983年 | 6篇 |
1980年 | 5篇 |
1978年 | 6篇 |
1975年 | 4篇 |
1971年 | 6篇 |
1969年 | 7篇 |
1968年 | 6篇 |
1967年 | 5篇 |
1964年 | 8篇 |
1963年 | 8篇 |
1962年 | 5篇 |
排序方式: 共有1273条查询结果,搜索用时 0 毫秒
71.
72.
73.
74.
75.
BACKGROUND: The National Kidney Foundation has recently published the Kidney Disease Outcomes Quality Initiative (K/DOQI) Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease (CKD). According to these guidelines, in patients with stage 5 CKD, the adjusted calcium level should be 8.4- 9.5 mg/dl, the serum phosphate should be 3.5-5.5 mg/dl, the calcium phosphorous product should be <55 mg(2)/dl(2) and the intact parathyroid hormone (PTH) level should be 150-300 pg/ml. METHODS: In order to evaluate our ability to meet these targets, we reviewed laboratory parameters of bone and mineral metabolism of 140 patients over a 6-month period in an inner city hemodialysis unit. Serum calcium and phosphate levels were determined using standard assays and PTH levels were determined using the Nichols Intact PTH assay. RESULTS: We found that the levels of serum calcium and serum phosphorus fell within the range recommended by the K/DOQI guidelines 49 and 36% of the time respectively. 57% of the determinations for calcium x phosphorus product were <55 mg(2)/dl(2). PTH levels were within the recommended values in 20% of the determinations. Only 7% of the determinations met all four criteria simultaneously in spite of meeting other K/DOQI targets such as hematocrit and dialysis adequacy. CONCLUSION: These data indicate that current practice for the management of bone and mineral metabolism in hemodialysis falls far short of meeting the K/DOQI guidelines. 相似文献
76.
Detection of C-erb B2 gene amplification in bilharzial associated bladder cancer using fluorescence in situ hybridization 总被引:1,自引:0,他引:1
BACKGROUND: Gene amplifications are common events in different tumor types and may confer diagnostic, prognostic, or therapeutic information for patient management. Fluorescence in situ hybridization (FISH) represents a standard methodologic approach for testing for this genetic alteration, as it is rapid, reproducible and extremely reliable in detecting presence of C-erb-B2 gene amplification for clinical utility. PATIENTS AND METHODS: In this study, FISH is used in a series of archival human bilharzial bladder cancer specimens to evaluate for the presence of cerbB-2 gene alterations in the most common malignant tumor in bilharzial endemic areas, e.g., Egypt and some other countries. The study included 40 cases, 30 males and 10 females. Their ages ranged between 30 years and 76 years (median: 51 years). Twenty-one cases had squamous cell carcinoma, 16 had transitional cell carcinoma, two had adenocarcinoma, and one case had undifferentiated carcinoma. RESULTS: Thirteen out of 40 tumor samples (32.5%) show evidence of true C-erb-B2 gene amplification. Of the remaining samples, 24 (60%) show no gene amplification and three (7.5%) fall into the borderline category with a ratio between one and two C-erb-B2 genes/cell relative to chromosome 17 centromeres. No evidence of chromosome 17 polysomy was found in any cases scored as single copy with the C-erb-B2 probe. CONCLUSION: No significant association was found between gene amplification and any of the tested clinicopathologic parameters or tumor recurrence except for tumor grade where higher tumor grades tended to be associated with more C-erb-B2 gene amplification (P = 0.01) thus reflecting more tumor aggressiveness. So, the amplification of C-erb-B2 in bilharzial associated bladder cancer is probably not independently related to clinical outcome of patients. 相似文献
77.
The reaction of 2-hydrazino-4-(4-methoxyphenyl)-6-pheny-nicotinonitrile 3 with halo compounds yielded 4a-c,5,6. Heating 3 with carbon disulphide gave 7-(4-methoxyphenyl)-5-phenyl-3-thioxo-2,3-dihydro [1,2,4-] triazolo [4,3-a] pyridine-8-carboxylic amide 7. The behaviour of 3 towards some alpha,beta-unsaturated nitriles ,ethoxymethylene and ketene dithioacetal derivatives has been investigated, affording 9a-c,11a-c,13a-c,16a,b respectively. The activity of compounds 4a,5,6 and 7 have been investigated as molluscicidal. 相似文献
78.
79.
Zawilla NH Abdul-Azim Mohammad M El kousy NM El-Moghazy Aly SM 《Journal of pharmaceutical and biomedical analysis》2003,32(6):1135-1144
Three sensitive and reproducible methods for quantitative determination of meloxicam (mel) in pure form and in pharmaceutical formulations are presented. The first method is high performance liquid chromatography by which the drug is determined in the presence of its degradation products over concentration range 100–500 μg ml−1 with mean percentage accuracy 100.13±0.53. The second method is based on measuring the absorbance of the formed neutral complex between basic methylene blue and mel in phosphate buffer (pH 8) at λ=653.5 nm over concentration range 1–5 μg ml−1 with mean percentage accuracy 99.12±1.18. The third method is based on reaction between 2,3-dichloro-5,6-dicyano-p-benzoquinone resulting in the formation of an intense orange red coloured product after heating in a boiling water bath for 5 min. The coloured product exhibits an absorption maximum at 455 nm, over concentration range 40–160 μg ml−1 with mean percentage accuracy 100.53±1.04. 相似文献
80.
Urocortin is an endogenous vasodilator peptide that is related to corticotrophin-releasing factor. We examined the haemodynamic effects of urocortin in thiobutabarbital-anaesthetized rats, via the triple-isotope microspheres technique. Urocortin (3 nmol/kg, i.v. bolus) reduced mean arterial pressure (-25 mm Hg) through a decrease in total peripheral resistance (-43%). This was associated with an increase in cardiac output (+24%) and vasodilatation of the following tissues: heart and stomach (approximately 300% of baseline); liver, intestine, caecum/colon, skeletal muscle and skin (approximately 200%); and testes (approximately 150%). Arterial conductances of the kidneys, spleen and brain were unaffected by urocortin. Neither the vehicle (0.9% NaCl) nor a low dose of urocortin (0.3 nmol/kg) altered any measurements. Therefore, urocortin causes generalized vasodilatation as follows: heart and stomach>liver, intestine, caecum/colon, skeletal muscle and skin>testes. 相似文献